These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10889514)

  • 1. Short-term adverse effects in humans of ingested mineral oils, their additives and possible contaminants--a review.
    Hard GC
    Hum Exp Toxicol; 2000 Mar; 19(3):158-72. PubMed ID: 10889514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Toxic oil syndrome--an example of an exogenously-induced autoimmune disease].
    Bell S; Brand K; Meurer M
    Hautarzt; 1992 Jun; 43(6):339-43. PubMed ID: 1628965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The toxic oil syndrome: 20 years on.
    Diggle GE
    Int J Clin Pract; 2001; 55(6):371-5. PubMed ID: 11501225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxic-oil syndrome: case reports associated with the ITH oil refinery in Sevilla.
    Posada M; Castro M; Kilbourne EM; Diaz de Rojas F; Abaitua I; Tabuenca JM; Vioque A
    Food Chem Toxicol; 1987 Jan; 25(1):87-90. PubMed ID: 3817664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral exposure to mineral oils: Is there an association with immune perturbation and autoimmunity?
    Kimber I; Carrillo JC
    Toxicology; 2016 Feb; 344-346():19-25. PubMed ID: 26821245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxic oil syndrome. A long-term follow-up of a cohort of 332 patients.
    Alonso-Ruiz A; Calabozo M; Perez-Ruiz F; Mancebo L
    Medicine (Baltimore); 1993 Sep; 72(5):285-95. PubMed ID: 8412642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid HPLC screening method for contaminants found in implicated L-tryptophan associated with eosinophilia myalgia syndrome and adulterated rapeseed oil associated with toxic oil syndrome.
    Williamson BL; Tomlinson AJ; Hurth KM; Posada de la Paz M; Gleich GJ; Naylor S
    Biomed Chromatogr; 1998; 12(5):255-61. PubMed ID: 9787895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manufacturing processes at two French rapeseed oil companies: possible relationships to toxic oil syndrome in Spain.
    Posada de la Paz M; Philen RM; Abaitua Borda I; Bernert JT; Gancedo JC; DuClos PJ; Kilbourne EM
    Food Chem Toxicol; 1991 Dec; 29(12):797-803. PubMed ID: 1765323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The toxic oil syndrome: a perspective on immunotoxicological mechanisms.
    Yoshida SH; German JB; Fletcher MP; Gershwin ME
    Regul Toxicol Pharmacol; 1994 Feb; 19(1):60-79. PubMed ID: 8159816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxic oil syndrome (TOS). Foreword.
    Posada M; Gelpi E
    Hum Exp Toxicol; 2000 Mar; 19(3):155-7. PubMed ID: 10889513
    [No Abstract]   [Full Text] [Related]  

  • 11. Toxic oil syndrome and eosinophilia-myalgia syndrome: May 8-10, 1991, World Health Organization meeting report.
    Philen RM; Posada M
    Semin Arthritis Rheum; 1993 Oct; 23(2):104-24. PubMed ID: 8266108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neurotoxicological aspects of the toxic oil syndrome (TOS) in Spain.
    Altenkirch H; Stoltenburg-Didinger G; Koeppel C
    Toxicology; 1988 Apr; 49(1):25-34. PubMed ID: 3287691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The toxic oil syndrome (TOS, 1981): from the disease towards a toxicological understanding of its chemical aetiology and mechanism.
    Aldridge WN
    Toxicol Lett; 1992 Dec; 64-65 Spec No():59-70. PubMed ID: 1471212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in tryptophan metabolism in the toxic oil syndrome and in the eosinophilia-myalgia syndrome.
    Silver RM; Sutherland SE; Carreira P; Heyes MP
    J Rheumatol; 1992 Jan; 19(1):69-73. PubMed ID: 1532618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of the alimentary toxic oil syndrome due to ingestion of denatured rapeseed oil.
    Gilsanz V; Alvarez JL; Serrano S; Simón J
    Arch Intern Med; 1984 Feb; 144(2):254-6. PubMed ID: 6696559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical-induced autoimmune reactions and Spanish toxic oil syndrome. Focus on hydantoins and related compounds.
    Kammüller ME; Bloksma N; Seinen W
    J Toxicol Clin Toxicol; 1988; 26(3-4):157-74. PubMed ID: 3047417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia.
    Silver RM
    Curr Opin Rheumatol; 1992 Dec; 4(6):851-6. PubMed ID: 1457280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the generation and outcome of 3-(N-phenylamino)propane-1,2-diol derivatives in deodorized model oils related to toxic oil syndrome.
    Morató A; Escabrós J; Manich A; Reig N; Castaño Y; Abián J; Messeguer A
    Chem Res Toxicol; 2005 Apr; 18(4):665-74. PubMed ID: 15833026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Petroleum mineral oil refining and evaluation of cancer hazard.
    Mackerer CR; Griffis LC; Grabowski JS; Reitman FA
    Appl Occup Environ Hyg; 2003 Nov; 18(11):890-901. PubMed ID: 14555442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological basis of toxic oil syndrome (TOS).
    Gallardo S; del Pozo V; Cárdaba B; de Andrés B; Martín-Orozco E; Fernandez JC; Tramón P; Posada M; Abaitua I; Palomino P
    Toxicology; 1994 Nov; 93(2-3):289-99. PubMed ID: 7974520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.